Cipla to build biosimilars plant in South Africa to serve global markets
Cipla will build a biosimilar production facility in Durban, South Africa.
Cipla will build a biosimilar production facility in Durban, South Africa.
A human plasma protein could make producing pluripotent stem cells cheaper and faster according to academics in the UK and Sweden and partner GE Healthcare.